Crozet BioPharma, LLC, a biotechnology company that specializes in developing medical countermeasures for infectious diseases and cancer, announced it is partnering with Public Health Vaccines, LLC (PHV) via a $10.8 million partnering agreement. The companies plan to develop and manufacture a vaOriginal Article
You may also like
Pharmaceutical Sales Customer Engagement –...
AstraZeneca’s Polyneuropathy Treatment Recommended...
Designing a Strategic Roadmap for Seamless Product...
AAPS PharmSci 360: LBFs and Tackling Oral Biologic...
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia...
GSK, Cambridge to Partner on R&D for Kidney and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.